In the present study, we elucidated a novel HCC cell proliferation mechanism involving PTPN13 and insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) that regulates metabolic reprogramming by affecting c-Myc mRNA stability. The gene discussed is PTPN13; the disease is hepatocellular carcinoma.